Population-based estimates of the number of transgender persons range from 0.5% to 1.3%
for birth-assigned male persons and from 0.4% to 1.2% for birth-assigned female persons. 1 …

… (T)-based gender-affirming hormone therapy (GAHT) on anthropometric parameters, body
composition, and glycolipid metabolism in assigned female at birth (AFAB) persons. The …

… assigned female at birth but identify as men, and transgender women are individuals who
were assigned … with congenital genitourinary anomalies who were assigned gender at birth (1,…

… experienced gender, instead of their assigned gender [1]. … gender identity (GI) and the
assigned gender at birth [3, 4]. GI … discrepancy between a person's assigned sex at birth and GI …

… Gender-affirming hormone therapy with either estradiol or testosterone for transgender
persons can significantly impact chemistry and hematology laboratory tests. The sex used for …

… female secondary sex characteristics) and 34 transgender men (persons assigned female
at … characteristics) presenting for initiation of hormone therapy at a community health center …

… assigned female at birth (AFAB) transgender and gender diverse (TGD) adolescents initiating
hormone therapy… testosterone gender-affirming hormone therapy between 2010 and 2019, …

… 4 groups based on sex assigned at birth and … assigned male at birth with no history of
hormone use (baseline TW), and TM with sex assigned female at birth with no history of hormone …

… termed assigned male sex at birth (AMAB), hormonal treatment … termed assigned female sex
at birth (AFAB), hormone treatment … Hormone replacement therapy is a risk factor for venous …

… trial who received oral combination therapy as it was among those assigned to placebo. Similar
… who received estrogen combined with progestin than among those assigned to placebo. …